Literature DB >> 22281980

Clinicopathological significance of E-cadherin, β-catenin and epidermal growth factor receptor expression in intrahepatic cholangiocarcinoma.

Mi Jin Gu1, Joon Hyuk Choi.   

Abstract

BACKGROUND/AIMS: The study investigated the pathogenetic role of e-cadherin, β-catenin, and epidermal growth factor receptor (EGFR) in cholangiocarcinoma (CC) and analyzed the correlation with clinicopathological factors.
METHODOLOGY: Eighty three patients with CC who had undergone resection were studied. The expression of E-cadherin, β-catenin and EGFR was examined by immunohistochemistry.
RESULTS: The down-regulation of E-cadherin and β-catenin was identified in 43/83 patients (51.8%) and 32/83 patients (38.6%), respectively. EGFR expression occurred in 46 of 83 patients (55.4%). The reduced membranous expression of E-cadherin was correlated with poor histological differentiation. The reduced membranous expression of β-catenin was correlated with higher tendency of vascular invasion and was more frequent in males. EGFR was more expressed in poorly differentiated CC. The reduced membranous expression of E-cadherin was significantly correlated with reduced expression of β-catenin.
CONCLUSIONS: The reduced expression of E-cadherin and β-catenin and EGFR over expression seems to be correlated with tumor differentiation and tumor progression than tumor invasion and tumor proliferation.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22281980     DOI: 10.5754/hge11881

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

Review 1.  Review to better understand the macroscopic subtypes and histogenesis of intrahepatic cholangiocarcinoma.

Authors:  Yuichi Sanada; Yujo Kawashita; Satomi Okada; Takashi Azuma; Shigetoshi Matsuo
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

2.  Expression Level of Genes Coding for Cell Adhesion Molecules of Cadherin Group in Colorectal Cancer Patients.

Authors:  Zbigniew Lorenc; Mieszko Norbert Opiłka; Celina Kruszniewska-Rajs; Antoni Rajs; Dariusz Waniczek; Małgorzata Starzewska; Justyna Lorenc; Urszula Mazurek
Journal:  Med Sci Monit       Date:  2015-07-13

3.  Expression and activation of EGFR and STAT3 during the multistage carcinogenesis of intrahepatic cholangiocarcinoma induced by 3'-methyl-4 dimethylaminoazobenzene in rats.

Authors:  Fan Zhang; Lianhong Li; Xingwu Yang; Bo Wang; Jinyao Zhao; Shilun Lu; Xiaotang Yu
Journal:  J Toxicol Pathol       Date:  2015-02-09       Impact factor: 1.628

4.  Unsectable cholangiocarcinoma: Additional therapy to chemoradiotherapy.

Authors:  Kamon Chaiyasit; Viroj Wiwanitkit
Journal:  Indian J Med Paediatr Oncol       Date:  2013-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.